Elomatic Logo

Engineering affordable healthcare

World map
Engineering Methodology
Beyond Engineering

Beyond Engineering

As part of our endeavour to provide end to end solutions for the life sciences sector, Elomatic is today in a position to facilitate the transfer of technology, analytical testing services and 3rd party regulatory support through its globally renowned principals in Europe, Asia and North America.

Elomatic has access to technologies for the production of complex molecules such as monoclonal antibodies, therapeutic proteins, generic and novel vaccines, bio-enzymes, classical fermentation based products as well as dossiers for many generic chemical synthesis based drugs.

Elomatic has also made provisions for third party regulatory reviews through its principals that have vast knowledge in this field and have hands on experience through their prior association with internationally recognized regulatory bodies.